SHR 4640Alternative Names: SHR-4640
Latest Information Update: 12 Jan 2017
Price : $50
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Small molecules; Uricosurics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Gout
Most Recent Events
- 01 Sep 2016 Phase-I clinical trials in Gout (In volunteers) in Australia (PO) (NCT03015948)
- 01 Jul 2016 Jiangsu HengRui Medicine Co initiates a phase I trial in Healthy volunteers in China (PO) (NCT02890966)
- 23 Jun 2016 Phase-I clinical trials in Gout (In volunteers) in China (PO) (NCT02815839)